Pain Management in the Elderly: An FDA Safe Use Initiative Expert Panel’s View on Preventable Harm Associated with NSAID Therapy

Taylor, Robert; Lemtouni, Salma; Weiss, Karen D.; Pergolizzi, Joseph V.

doi:10.1155/2012/196159

Cited by 22 publications

(12 citation statements)

References 50 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, due to potential liver toxicity, patients should be counseled not to consume more than 3000mg of acetaminophen per day. It is also important to educate patients and their caregivers that many other medications, including over the counter medications, contain acetaminophen and require caution when used in combination (9). …”

Section: Assessment and Management Of Painmentioning

confidence: 99%

Palliative Care and Symptom Management in Older Patients with Cancer

Krause

Goldberg

Korc‐Grodzicki

2016

Clinics in Geriatric Medicine

View full text Add to dashboard Cite

SYNOPSIS Older cancer patients are best served by a multidisciplinary approach with Palliative Care (PC) playing an integral role. PC focuses on symptom control irrespective of its cause and should not be associated only with terminal care. It provides an additional layer of support in the care of the cancer patient with an emphasis on quality of life. In this article, we discuss the evaluation and management of pain and other common non-pain symptoms that occur in the elderly cancer patient, as well as end of life care.

show abstract

Section: Assessment and Management Of Painmentioning

confidence: 99%

Palliative Care and Symptom Management in Older Patients with Cancer

Krause

Goldberg

Korc‐Grodzicki

2016

Clinics in Geriatric Medicine

View full text Add to dashboard Cite

show abstract

“…109 A lack of awareness and adherence contribute to the barriers to optimal care and management with NSAIDs. 31, Studies show that these analgesics are being inappropriately used and prescribed.…”

Section: Barriers To Treatmentmentioning

confidence: 99%

NSAIDs for Musculoskeletal Pain Management: Current Perspectives and Novel Strategies to Improve Safety

Atchison¹,

Herndon²,

Rusie³

2013

JMCP

View full text Add to dashboard Cite

and completed residency training in physical medicine and rehabilitation at The Ohio State University. Dr. Atchison has been in practice at academic medical centers for more than 20 years, serving on the faculty at the University of Kentucky and University of Florida before his appointment at Northwestern University. A recognized teacher and researcher in the field of pain management and rehabilitation, he has presented courses, lectures, and workshops nationally and internationally on pharmacological and nonpharmacological therapies, care of spinal injuries, and spinal manipulation. Dr. Atchison has led and participated in many research projects, including several funded by the National Institutes of Health. He has authored numerous research papers and book chapters, and he serves as a peer reviewer for the Archives of Physical Medicine and Rehabilitation. He has been a member of the editorial boards of the Supplement Policy Statement Standards for Supplements to the Journal of Managed Care PharmacySupplements to the Journal of Managed Care Pharmacy are intended to support medical education and research in areas of clinical practice, health care quality improvement, or efficient administration and delivery of health benefits. The following standards are applied to all JMCP supplements to ensure quality and assist readers in evaluating potential bias and determining alternate explanations for findings and results. 1. Disclose the principal sources of funding in a manner that permits easy recognition by the reader. 2. Disclose the existence of all potential conflicts of interest among supplement contributors, including financial or personal bias. 3. Describe all drugs by generic name unless the use of the brand name is necessary to reduce the opportunity for confusion among readers. 4. Identify any off-label (unapproved) use by drug name and specific off-label indication. 5. Strive to report subjects of current interest to managed care pharmacists and other managed care professionals. S14 Multitarget Drugs S15 Conclusions S15 References Target AudiencesThis CME/CE activity is designed to meet the educational needs of pharmacists, physicians, nurse practitioners, and nurses. Learning Objectives• Assess patient-specific risk factors in selecting NSAIDs for mild-to-moderate musculoskeletal pain • Incorporate risk/benefit analysis in decision making about NSAID use • Use evidence-based guidelines for selecting NSAID therapy and applying strategies to prevent complications • Evaluate the efficacy, safety, and pharmacological profile of new and emerging NSAID formulations Funding This supplement was funded by an independent educational grant to PRIME Education, Inc. (PRIME) from Iroko Pharmaceuticals, LLC. Accreditation StatementsIn support of improving patient care, PRIME Education, Inc. (PRIME) is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing educat...

show abstract

“…A kritikátlan vagy hibás tájékoztatáson alapuló öngyógyszerelés, a környezet és a gyógyítóteam esetleges téves tájékoztatása is szerepel a felismerendő kockázatok között. Az idős beteg ellátóinak viszont tisztában kell lennie ezekkel a kockázatokkal, megkülönböztetett figyelemmel kell kísér-nük az idős beteget, aktívan tájékozódniuk kell a beteg korlátai felől és el kell látniuk a biztonságos gyógyszer-szedéshez szükséges információkkal [68][69][70].…”

Section: A Nem Szteroid Gyulladáscsökkentők Potenciális Nemkívánatos unclassified

Nem szteroid gyulladáscsökkentők peroralis és transdermalis alkalmazása regionális mozgásszervi fájdalmi szindrómákban

et al. 2017

View full text Add to dashboard Cite

A tanulmány szerzői a napi gyakorlatban a leggyakrabban fellépő mozgásszervi panaszok hátterében álló regionális fájdalmi szindrómák leggyakoribb kezelési módjával, a per os és transdermalisan alkalmazott nem szteroid gyulladás-csökkentőkkel végzett fájdalomcsillapításról rendelkezésre álló bizonyítékokat gyűjtötték össze. Azon szakterülete-ken működők számára, akik leggyakrabban találkoznak az átmeneti és fájdalmas epizódokkal (háziorvosok, reumatológusok, ortopédek, foglalkozás-egészségügyi és sportorvosok), külön meghatározták a foglalkozási vagy sporttevékenységük (a mozgásszervek ismétlődő vagy nagy energiájú igénybevétele) miatt kockázatnak kitettek körét és ismertetik fájdalmaik patológiai magyarázatát. A fájdalomcsillapítás eszközei között részletezik a nem szteroid gyulladáscsökkentők hatásának módját és farmakológiai sajátosságait. Kiemelik a gyógyszeres kezelés kockázatait és az emiatt veszélyeztettek speciális csoportjait (gyermekkorúak és idősek). Az általános fájdalomcsillapítási alapelvek és stratégiák ismertetésén túlmenően a hazai és nemzetközi irányelvekből a tanulmány tárgyára vonatkozó ajánlásokat adják közre. Orv Hetil. 2017; 158(Suppl. 3): 3-30.Kulcsszavak: nem szteroid gyulladáscsökkentők, regionális mozgásszervi fájdalmi szindrómák, mozgásszervi foglalkozási és sportbetegségek Peroral and transdermal application of non-steroidal anti-inflammatory drugs (NSAIDs) for the treatment of regional musculoskeletal pain syndromesIn this review the available evidences regarding the most frequently applied medication (peroral and transdermal non-steroidal anti-inflammatory agents) for the most frequent musculoskeletal complaints (regional pain syndromes) have been collected for the appropriate medical professionals who are most frequently faced with these conditions (general practitioners, rheumatologists, orthopedics, occupational and sports medicine experts). The special population at risk (with repeated and high energy overuse because of occupational or sport activities) and the pathology of their syndromes are identified. Mode of action, pharmacological properties of the non-steroidal anti-inflammatory drugs and the unwanted effects of their application especially in infants and elderly are highlighted. Recommendations of the general and specific pain management guidelines have been selected and listed in the review.

show abstract

Pain Management in the Elderly: An FDA Safe Use Initiative Expert Panel’s View on Preventable Harm Associated with NSAID Therapy

Cited by 22 publications

References 50 publications

Palliative Care and Symptom Management in Older Patients with Cancer

Palliative Care and Symptom Management in Older Patients with Cancer

NSAIDs for Musculoskeletal Pain Management: Current Perspectives and Novel Strategies to Improve Safety

Nem szteroid gyulladáscsökkentők peroralis és transdermalis alkalmazása regionális mozgásszervi fájdalmi szindrómákban

Contact Info

Product

Resources

About